2 stories mentioning BOM:530233Updated 32d ago
Every FINWIRES story that references BOM:530233, newest first.
Auro Laboratories (BOM:530233) said that Chief Financial Officer Kuntal Pancholi has resigned effective May 28, citing personal reasons, according to a same-day filing on BSE.Shares of the company rose nearly 1% in Friday's trade.
Auro Laboratories (BOM:530233) received an Attestation of Inspection from the European Directorate for the Quality of Medicines and Healthcare (EDQM) for its Metformin Hydrochloride CEP dossier, according to a Tuesday filing on BSE.Shares of the company rose nearly 4% in Wednesdays trade.The certification confirms compliance with Good Manufacturing Practice (GMP) requirements under EU rules for its MIDC Tarapur facility, the filing said.
